Grandis JR - Search Results

1

Serum biomarker modulation following molecular targeting of epidermal growth factor and cyclooxygenase pathways: a pilot randomized trial in head and neck cancer.

Moskowitz HS, Gooding WE, Thomas SM, Freilino ML, Gross N, Argiris A, Grandis JR, Ferris RL. Moskowitz HS, et al. Among authors: grandis jr. Oral Oncol. 2012 Nov;48(11):1136-45. doi: 10.1016/j.oraloncology.2012.05.015. Epub 2012 Jun 23. Oral Oncol. 2012. PMID: 22732263 Free PMC article. Clinical Trial.

2

Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.

Grandis JR, Tweardy DJ. Grandis JR, et al. Cancer Res. 1993 Aug 1;53(15):3579-84. Cancer Res. 1993. PMID: 8339264

3

TGF-alpha and EGFR in head and neck cancer.

Grandis JR, Tweardy DJ. Grandis JR, et al. J Cell Biochem Suppl. 1993;17F:188-91. doi: 10.1002/jcb.240531027. J Cell Biochem Suppl. 1993. PMID: 8412192 Review.

4

Normalization of EGFR mRNA levels following restoration of wild-type p53 in a head and neck squamous cell carcinoma cell line.

Grandis JR, Zeng Q, Drenning SD, Tweardy DJ. Grandis JR, et al. Int J Oncol. 1998 Aug;13(2):375-8. doi: 10.3892/ijo.13.2.375. Int J Oncol. 1998. PMID: 9664135

5

STAT signaling in head and neck cancer.

Song JI, Grandis JR. Song JI, et al. Among authors: grandis jr. Oncogene. 2000 May 15;19(21):2489-95. doi: 10.1038/sj.onc.1203483. Oncogene. 2000. PMID: 10851047 Review.

6

Determination of intermediate biomarker expression levels by quantitative reverse transcription-polymerase chain reaction in oral mucosa of cancer patients treated with liarozole.

Zeng Q, Smith DC, Suscovich TJ, Gooding WE, Trump DL, Grandis JR. Zeng Q, et al. Among authors: grandis jr. Clin Cancer Res. 2000 Jun;6(6):2245-51. Clin Cancer Res. 2000. PMID: 10873074 Clinical Trial.

7

Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.

Grandis JR, Falkner DM, Melhem MF, Gooding WE, Drenning SD, Morel PA. Grandis JR, et al. Clin Cancer Res. 2000 Jul;6(7):2794-802. Clin Cancer Res. 2000. PMID: 10914726

8

The role of topical antibiotic prophylaxis in patients undergoing contaminated head and neck surgery with flap reconstruction.

Simons JP, Johnson JT, Yu VL, Vickers RM, Gooding WE, Myers EN, Pou AM, Wagner RL, Grandis JR. Simons JP, et al. Among authors: grandis jr. Laryngoscope. 2001 Feb;111(2):329-35. doi: 10.1097/00005537-200102000-00026. Laryngoscope. 2001. PMID: 11210884 Clinical Trial.

9

Targeting growth factor receptors: integration of novel therapeutics in the management of head and neck cancer.

Lango MN, Shin DM, Grandis JR. Lango MN, et al. Among authors: grandis jr. Curr Opin Oncol. 2001 May;13(3):168-75. doi: 10.1097/00001622-200105000-00007. Curr Opin Oncol. 2001. PMID: 11307060 Review.

10

Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.

Song JI, Lango MN, Hwang JD, Drenning SD, Zeng Q, Lamph WW, Grandis JR. Song JI, et al. Among authors: grandis jr. Cancer Res. 2001 Aug 1;61(15):5919-25. Cancer Res. 2001. PMID: 11479234

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

384 results

Search Page

Filters